Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionSignaturefd, Llc
Latest Disclosed Ownership48,040 shares
Latest Disclosed Value $ 7,338,168
Signaturefd, Llc reports 3.03% increase in ownership of NVS / Novartis AG - Depositary Receipt (Common Stock)

On April 7, 2026 - Signaturefd, Llc filed a 13F-HR form disclosing ownership of 48,040 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $7,338,110 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 46,629 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 3.03% during the quarter. The current value of the position is $7,165,646 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-07 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 48,040 1,411 3.03 7,338 14.16 0.1125
2026-01-20 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 46,629 522 1.13 6,429 8.73 0.0982
2025-10-21 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 46,107 1,389 3.11 5,913 9.26 0.0932
2025-07-16 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 44,718 1,627 3.78 5,411 12.66 0.0922
2025-05-02 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 43,091 3,001 7.49 4,804 23.12 0.0909
2025-02-10 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 40,090 -396 -0.98 3,901 -16.22 0.0739
2024-10-21 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 40,486 1,718 4.43 4,657 12.82 0.0887
2024-07-29 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 38,768 2,244 6.14 4,127 16.85 0.0838
2024-05-03 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 36,524 1,061 2.99 3,533 -1.34 0.0746
2024-02-01 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 35,463 996 2.89 3,581 1.99 0.0827
2023-11-03 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 34,467 3,443 11.10 3,511 12.14 0.0914
2023-08-01 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 31,024 2,341 8.16 3,131 18.65 0.0800
2023-04-28 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 28,683 1,979 7.41 2,639 8.92 0.0720
2023-01-30 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 26,704 2,465 10.17 2,423 31.49 0.0708
2022-11-08 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 24,239 944 4.05 1,842 -6.45 0.0631
2022-08-10 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 23,295 257 1.12 1,969 -2.62 0.0670
2022-05-02 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 23,038 3,455 17.64 2,022 18.04 0.0609
2022-01-25 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 19,583 -692 -3.41 1,713 3.32 0.0527
2021-10-28 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 20,275 -466 -2.25 1,658 -12.37 0.0573
2021-07-26 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 20,741 2,046 10.94 1,892 18.40 0.0755
2021-04-30 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 18,695 155 0.84 1,598 -8.74 0.0707
2021-02-11 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 18,540 544 3.02 1,751 11.88 0.0825
2020-11-03 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 17,996 -561 -3.02 1,565 -3.45 0.0838
2020-07-30 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 18,557 2,087 12.67 1,621 19.37 0.0979
2020-04-23 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 16,470 -3,466 -17.39 1,358 -28.07 0.1174
2020-02-05 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 19,936 4,348 27.89 1,888 39.34 0.1394
2019-10-16 2019-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 15,588 360 2.36 1,355 -2.52 0.1113
2019-07-31 2019-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 15,228 372 2.50 1,390 -2.66 0.1202
2019-05-09 2019-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 14,856 847 6.05 1,428 18.80 0.1215
2019-02-13 2018-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 14,009 2,363 20.29 1,202 19.84 0.1120
2018-11-14 2018-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 11,646 1,719 17.32 1,003 33.73 0.1019
2018-08-14 2018-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 9,927 161 1.65 750 -5.06 0.0837
2018-05-08 2018-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 9,766 1,359 16.17 790 11.90 0.0927
2018-02-13 2017-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 8,407 1,926 29.72 706 26.98 0.0851
2017-11-14 2017-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 6,481 -1,751 -21.27 556 -19.07 0.0738
2017-08-14 2017-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 8,232 -3,241 -28.25 687 -19.37 0.0999
2017-05-15 2017-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 11,473 7,870 218.43 852 225.19 0.1262
2017-02-14 2016-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,603 -1,675 -31.74 262 -37.17 0.0440
2016-11-14 2016-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 5,278 1,264 31.49 417 25.98 0.0609
2016-07-29 2016-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 4,014 774 23.89 331 40.85 0.0484
2016-05-12 2016-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,240 815 33.61 235 12.44 0.0401
2016-01-22 2015-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,425 16 0.66 209 -5.43 0.0405
2015-10-23 2015-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 2,409 611 33.98 221 24.86 0.0504
2015-07-15 2015-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 1,798 619 52.50 177 52.59 0.0384
2015-04-15 2015-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 1,179 -90 -7.09 116 -1.69 0.0281
2015-02-13 2014-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 1,269 343 37.04 118 35.63 0.0293
2014-11-13 2014-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 926 -35 -3.64 87 0.00 0.0284
2014-08-14 2014-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 961 -598 -38.36 87 -34.59 0.0303
2014-05-16 2014-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 1,559 -427 -21.50 133 -16.87 0.0535
2014-02-11 2013-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 1,986 752 60.94 160 68.42 0.0583
2013-11-13 2013-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 1,234 710 135.50 95 156.76 0.0407
2013-08-14 2013-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 524 524 37 0.0191
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.